The European Bank for Reconstruction and Development (EBRD) has approved an equity investment of up to $75 million for the acquisition of Egyptian generic-drug maker Adwia Pharmaceuticals.

EBRD has partnered with a group of co-investors – CDC, a development finance institution funded by the UK government, and ADP III, a private equity fund advised by Development Partners...